Lessons learned from the CRUSADE National Quality Improvement Initiative
The CRUSADE National Quality Improvement Initiative was created to track national care patterns, facilitate process improvement, and improve patient outcomes among patients with acute coronary syndromes (ACS). CRUSADE found that patients in community practice were sicker than those in randomized clinical trials and often failed to receive evidence-based therapies. Dosing regimens of antithrombotic therapy were also suboptimal, raising safety concerns. Over time, guideline adherence and dosing regimens of ACS patients have improved dramatically, leading to significantly improved outcomes. Ongoing quality improvement efforts will be needed to further improve evidence-based and personalized care of patients with ACS.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 2.Braunwald E, Antman EM, Beasley JW, et al.: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2002, 40:1366–1374.PubMedCrossRefGoogle Scholar
- 3.Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. The PURSUIT Trial Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy [no authors listed]. N Engl J Med 1998, 339:436–443.CrossRefGoogle Scholar
- 6.Cohen M, Demers C, Gurfinkel EP, et al.: A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997, 337:447–452.PubMedCrossRefGoogle Scholar
- 11.Wallentin L, Lagerqvist B, Husted S, et al.: Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000, 356:9–16.PubMedCrossRefGoogle Scholar
- 12.Anderson JL, Adams CD, Antman EM, et al.: ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1–e157.PubMedCrossRefGoogle Scholar
- 16.Ferguson JJ, Califf RM, Antman EM, et al.: Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004, 292:45–54.PubMedCrossRefGoogle Scholar
- 25.Blomkalns AL, Chen AY, Hochman JS, et al.: Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative. J Am Coll Cardiol 2005, 45:832–837.PubMedCrossRefGoogle Scholar
- 26.Sonel AF, Good CB, Mulgund J, et al.: Racial variations in treatment and outcomes of black and white patients with high-risk non-ST-elevation acute coronary syndromes: insights from CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC/AHA Guidelines?). Circulation 2005, 111:1225–1232.PubMedCrossRefGoogle Scholar
- 30.Alexander KP, Chen AY, Newby LK, et al.: Sex differences in major bleeding with glycoprotein IIb/IIIa inhibitors: results from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) initiative. Circulation 2006, 114:1380–1387.PubMedCrossRefGoogle Scholar
- 32.Fox KA, Poole-Wilson PA, Henderson RA, et al.: Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002, 360:743–751.PubMedCrossRefGoogle Scholar
- 38.Alexander KP, Chen AY, Roe MT, et al.: Decline in GP 2b3a Inhibitor Overdosing with Site-Specific Feedback in CRUSADE. Circulation 2007, 116(16 Suppl II):798–799.Google Scholar
- 40.Glickman SW, Boulding W, Staelin R, et al.: A framework for quality improvement: an analysis of factors responsible for improvement at hospitals participating in the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J 2007, 154:1206–1220.PubMedCrossRefGoogle Scholar